Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 1734325.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the planning of MRI protocols to monitor disease activity in multiple sclerosis (MS), the clinical subtype needs to be considered. In this serial gadolinium-enhanced MRI study, we demonstrated differences between patients with early relapsing/remitting MS and benign MS in both the production of new lesions and the occurrence of enhancement.
Medical subject headings
- Image Enhancement
- Magnetic Resonance Imaging
- Multiple Sclerosis
- Organometallic Compounds
- Pentetic Acid